Cargando…

Do participants in major, practice-changing breast cancer trials reflect the breast cancer patient population?

Detalles Bibliográficos
Autores principales:	Treweek, Shaun, Dryden, Ruth, McCowan, Colin, Harrow, Alison, Thompson, Alastair
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3980886/ http://dx.doi.org/10.1186/1745-6215-14-S1-P33

Ejemplares similares

A hard pill to swallow: a qualitative study of women's experiences of adjuvant endocrine therapy for breast cancer
por: Harrow, Alison, et al.
Publicado: (2014)

Do trial managers know when sites will fail to recruit? Preliminary results from the estimating site performance (ESP) study
por: Shearer, Kirsty, et al.
Publicado: (2015)

Trial forge – working together to make trials more efficient
por: Treweek, Shaun
Publicado: (2015)

What do we know about who does and does not attend general health checks? Findings from a narrative scoping review
por: Dryden, Ruth, et al.
Publicado: (2012)

Completion of 5-year adjuvant endocrine therapy in the community
por: Makubate, B, et al.
Publicado: (2010)

Do bone scans add to CT in detecting skeletal metastases in breast cancer staging?
por: Anand, Anuradha, et al.
Publicado: (2015)

Breast cancer screening - how do we communicate with women of South Asian origin?
por: Jain, AK, et al.
Publicado: (2009)

Breast density as a predictor of breast cancer risk
por: Lip, G, et al.
Publicado: (2010)

Lack of correlation between markers of breast cancer initiating cells
por: Liu, Y, et al.
Publicado: (2010)

P04.11. Factors associated with willingness to participate in a yoga clinical trial among breast cancer survivors
por: Desai, K, et al.
Publicado: (2012)

The impact of body mass index on age at breast cancer diagnosis and breast cancer phenotype
por: Brouckaert, Olivier, et al.
Publicado: (2015)

Ultrasound staging and fine needle aspiration cytology: how well do they predict breast cancer nodal involvement?
por: Schneider, JM, et al.
Publicado: (2011)

Chromosome translocations in breast cancer
por: Howarth, K, et al.
Publicado: (2008)

Breast cancer and environmental factors
por: Paulo, J Vicente, et al.
Publicado: (2010)

Do international standards for hygienic handrubs reflect realistic usage?
por: Wilkinson, MAC, et al.
Publicado: (2015)

Evaluation of migration-stimulating factor expression for breast cancer diagnosis and prognosis
por: Jones, SJ, et al.
Publicado: (2006)

Digital breast screening: does it do what it says on the tin?
por: Teape, A, et al.
Publicado: (2008)

Knowledge about breast cancer and attitudes to seeking help with breast cancer symptoms among older women
por: Linsell, L, et al.
Publicado: (2006)

P05.63. Perspectives of breast cancer survivors about participating in an acupuncture clinical trial for hot flashes: a qualitative study
por: Seluzicki, C, et al.
Publicado: (2012)

Comparison of the expression profile in breast cancer and ovarian cancer
por: Jarzab, M, et al.
Publicado: (2005)

How best to design a clinical trial that is relevant to practice? Applying PRECIS-2, a trial design tool, to primary care trials
por: Forbes, Gordon, et al.
Publicado: (2015)

Matching trial design decisions to the needs of those you hope will use the results: the PRECIS-2 tool
por: Loudon, Kirsty, et al.
Publicado: (2015)

Breast cancer knowledge among women with learning disabilities and their experiences of breast mammography
por: Taggart, LG, et al.
Publicado: (2010)

Comparison of MRI and digital breast tomosynthesis in the preoperative evaluation of multifocal breast cancer
por: Batohi, Bhavna, et al.
Publicado: (2015)

Molecular characterization of breast cell lines: a tool for breast cancer studies
por: Charafe-Jauffret, E, et al.
Publicado: (2005)

RhoBTB2 in breast cancer
por: McKinnon, CM, et al.
Publicado: (2010)

Breast cancer in young identical twins
por: Willson, SA, et al.
Publicado: (2008)

The NEUREGULIN1 gene and breast cancer
por: Chua, YL, et al.
Publicado: (2006)

Inhibitor of apoptosis proteins in breast cancer
por: Foster, FM, et al.
Publicado: (2006)

Health inequalities in breast cancer screening
por: Tollitt, J, et al.
Publicado: (2008)

Breast cancer screening in the over 70s
por: Eddy, D, et al.
Publicado: (2010)

Metabolic transformations in breast cancer subtypes
por: Mitra, Devina, et al.
Publicado: (2014)

Detection of minimal disease in breast cancer
por: Bosma, AJ, et al.
Publicado: (2005)

Breast cancers missed by the arbitration process
por: Lee, CM, et al.
Publicado: (2009)

Why do most c-erbB-2/HER-2-positive breast cancer patients fail to respond to Herceptin?
por: Murphy, ML, et al.
Publicado: (2006)

Why do most c-erbB-2/HER-2-positive breast cancer patients fail to respond to Herceptin?
por: Murphy, ML, et al.
Publicado: (2008)

Clinical recall from the NHS Breast Screening Programme: is it worth doing?
por: Morgan, M, et al.
Publicado: (2012)

PB.23. Breast density in previous screening mammograms of women with and without breast cancer
por: Sivagnanam, L, et al.
Publicado: (2014)

Flow-cytometry phenotypic assessment of immune cell subsets reflecting function for the identification of breast cancer patients receiving vaccine plus docetaxel with longer progression-free survival
por: Grenga, Italia, et al.
Publicado: (2013)

Lynch Syndrome - is breast cancer a feature?
por: Catts, Zohra Ali-Khan, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_96p3vhg6fvjtkl0ue9cu8j3n9j